Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Cyst Fibros. 2016 Jul 26;16(1):132–138. doi: 10.1016/j.jcf.2016.07.006

Figure 1. Urine Prostaglandin E Metabolite (PGE-M) Analysis.

Figure 1

(A) The change in urine PGE-M for all 40 participants before and after treatment with ivacaftor; p< 0.001 by Wilcoxon signed rank test. (B) The change in urine PGE-M before and after ivacaftor with the elevated outliers (n=8) removed; p<0.05 by Wilcoxon signed rank test.